About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 475 record(s)
Req # 2A-2020-27504
I would like to get information on the number of employees at IRCC (according to the sectors) who do not have citizenship status but working on a full-time contract (except the ones working on casual contracts). I would also like to know the…Organization: Immigration, Refugees and Citizenship Canada
August 2020
Req # 2A-2020-01732
Requesting all manuals, policies, guidelines and training material currently being used by visa officers processing permanent resident visa applications under the Refugee Classes (resettled refugees) in any stream (Government-Assisted, Privately…Organization: Immigration, Refugees and Citizenship Canada
August 2020
Req # A-2020-01436
Copies of reports, discussions, briefings, memos and decisions related to the introductory price review for erenumab (Aimovig) from January 2018 to February 2020.Organization: Patented Medicine Prices Review Board Canada
August 2020
Req # A-2020-04137
Copies of the PMPRB documentation related to the scientific review and pricing review of erenumab (Aimovig) from January 2018 to February 2020.Organization: Patented Medicine Prices Review Board Canada
August 2020
Nothing to report this month
Organization: Northern Pipeline Agency Canada